We visited Dr. Kees Jalink of the Biophysics of Cell Signaling group at the Netherlands Cancer Institute. His research group purchased the first ever LIFA to leave the labs of Lambert Instruments. Ten years later, the LIFA is still their fluorescence lifetime imaging method of choice for studying signal transduction pathways in living cells.
“Cancer can only be truely understood by knowing it in great detail,” says Jalink, “that is, by knowing exactly where and when signal transduction pathways become activated. Tools to study signals must yield data with spatial and temporal detail from living cells, preferably from cells that are as much as possible in a natural environment.”
“We use FRET sensors to study living cells. So for us, some of the other fluorescence lifetime imaging methods are just unacceptably slow. Our researchers are always in a hurry, because the cells they want to study expire within a couple of hours. The LIFA allows us to quickly record fluorescence lifetime images and immediately see a visualization of the results. It is the only way to quickly gather quantitative FLIM data.”